NASDAQ:IVF INVO Fertility (IVF) Stock Price, News & Analysis $0.86 -0.01 (-1.31%) As of 07/3/2025 12:54 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsSEC FilingsTrendsBuy This Stock About INVO Fertility Stock (NASDAQ:IVF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get INVO Fertility alerts:Sign Up Key Stats Today's Range$0.84▼$0.8750-Day Range N/A52-Week Range$0.82▼$17.04Volume54,365 shsAverage Volume564,780 shsMarket Capitalization$1.87 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview NAYA Biosciences (NASDAQ: NAYA) is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases, and fertility. Our hub & spoke model harnesses the shared resources of a parent company and agility of lean strategic franchises, enabling efficient acquisition, development, and partnering of assets as well as optimized return on investment by combining the upside of innovative clinical-stage therapeutics with scalable, profitable commercial revenues. NAYA’s expanding portfolio of assets currently includes NY-303, a GPC3 and NKp46 targeting bispecific antibody for the treatment of hepatocellular carcinoma (HCC) with a unique mode of action targeting non-responders to the current immunotherapy standard of care (approximately 70% of the current treatable market) cleared to enroll patients in a Phase I/II monotherapy trial in early 2025, NY-338, a CD38 and NKp46 targeting bispecific antibody for the treatment of multiple myeloma and autoimmune diseases with a differentiated safety and efficacy profile, and INVOcell®, an FDA-approved fertility device which has demonstrated comparable success rates to traditional In Vitro Fertilization (IVF). Read More Receive IVF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for INVO Fertility and its competitors with MarketBeat's FREE daily newsletter. Email Address IVF Stock News HeadlinesINVO Fertility Adds Platelet-Rich Plasma Therapy Capabilities at Wisconsin Fertility InstituteJune 30, 2025 | globenewswire.comINVO Fertility Receives Notice of Allowance for Modified INVOcell Device PatentJune 25, 2025 | globenewswire.comA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. July 6 at 2:00 AM | Porter & Company (Ad)INVO Fertility Reminds Shareholders to Cast Their Vote for Upcoming Annual Meeting of Shareholders to be held on Wednesday, June 25, 2025 at 12:00 p.m. Eastern TimeJune 20, 2025 | globenewswire.comINVO Fertility Expands Telehealth Capabilities at Its Wisconsin Fertility InstituteJune 18, 2025 | globenewswire.comINVO Fertility's Wisconsin Clinic Recognized on Newsweek's List of America's Best Fertility Clinics for 2025June 16, 2025 | globenewswire.comINVO Fertility to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025May 27, 2025 | globenewswire.comINVO Fertility, Inc. Reports Q1 2025 Financial Results and Strategic Focus on Core Fertility OperationsMay 20, 2025 | quiverquant.comQSee More Headlines IVF Stock Analysis - Frequently Asked Questions How have IVF shares performed this year? INVO Fertility's stock was trading at $2.18 on January 1st, 2025. Since then, IVF shares have decreased by 60.4% and is now trading at $0.8640. How were INVO Fertility's earnings last quarter? INVO Fertility, Inc (NASDAQ:IVF) issued its quarterly earnings data on Tuesday, May, 20th. The company reported ($12.53) EPS for the quarter. The business had revenue of $1.64 million for the quarter. How do I buy shares of INVO Fertility? Shares of IVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/20/2025Today7/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical Services Sub-IndustryMedical Equipment Current SymbolNASDAQ:IVF CIK1417926 WebN/A Phone(978) 878-9505FaxN/AEmployees10Year FoundedN/AProfitability EPS (Trailing Twelve Months)($34.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$9.10 million Net Margins-377.73% Pretax Margin-378.10% Return on EquityN/A Return on Assets-88.18% Debt Debt-to-Equity RatioN/A Current Ratio0.08 Quick Ratio0.07 Sales & Book Value Annual Sales$6.53 million Price / Sales0.29 Cash FlowN/A Price / Cash FlowN/A Book Value($29.86) per share Price / Book-0.03Miscellaneous Outstanding Shares2,160,000Free Float2,149,000Market Cap$1.87 million OptionableN/A Beta2.04 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report This page (NASDAQ:IVF) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredTrump’s BIGGEST setup yet.After another undefeated quarter, “Market Wizard” Larry Benedict is sounding the alarm on a $194 trillion mark...Brownstone Research | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INVO Fertility, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share INVO Fertility With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.